Lori Calabrese is a Psychiatry physician affiliated with International Union for Circumpolar Health. OpenAlex indexes 14 publications with 324 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1330 Sullivan Ave
South Windsor, CT 060742713
Telephone
860-648-9755Registry record last updated 8 Jul 2007.
Clinical trials
- Modified Ketogenic Diet and Ketamine for Anorexia Nervosa
Sponsor: Homeostasis Therapeutics, LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Teva Pharmaceuticals USA, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.2%SSRI21.2%Trazodone Hcl35%Escitalopram Oxalate25%Sertraline Hcl18%Fluoxetine Hcl9%Paroxetine Hcl7%Citalopram Hbr4%Fluvoxamine Maleate3%Part D<11 patientsSNRI14.7%Duloxetine Hcl40%Venlafaxine Hcl Er36%Desvenlafaxine Succinate Er16%Fetzima6%Venlafaxine Hcl3%Part D<11 patients+ 22 more classes in this area
Hormonal (systemic)
1.5%l-Thyroxine1.5%Levothyroxine Sodium68%Synthroid32%Part D<11 patientsCardiovascular
1.4%Beta blocker1.4%Propranolol Hcl Er67%Propranolol Hcl33%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Remission of OCD and ulcerative colitis with a ketogenic diet: Case Report
Frontiers in Psychiatry
2025 - Complete remission of depression and anxiety using a ketogenic diet: case series
Frontiers in Nutrition
2024 - Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”